147 related articles for article (PubMed ID: 1429879)
21. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts.
Viereck V; Siggelkow H; Tauber S; Raddatz D; Schutze N; Hüfner M
J Cell Biochem; 2002; 86(2):348-56. PubMed ID: 12112004
[TBL] [Abstract][Full Text] [Related]
22. Variations in vitamin D receptor transcription factor complexes associated with the osteocalcin gene vitamin D responsive element in osteoblasts and osteosarcoma cells.
Shakoori AR; van Wijnen AJ; Bortell R; Owen TA; Stein JL; Lian JB; Stein GS
J Cell Biochem; 1994 Jun; 55(2):218-29. PubMed ID: 8089197
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of endothelin receptors on rat osteoblastic osteosarcoma cells: down-regulation by 1,25-dihydroxy-vitamin D3.
Nambi P; Wu HL; Lipshutz D; Prabhakar U
Mol Pharmacol; 1995 Feb; 47(2):266-71. PubMed ID: 7870034
[TBL] [Abstract][Full Text] [Related]
24. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
25. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.
Norman AW; Bouillon R; Farach-Carson MC; Bishop JE; Zhou LX; Nemere I; Zhao J; Muralidharan KR; Okamura WH
J Biol Chem; 1993 Sep; 268(27):20022-30. PubMed ID: 8397195
[TBL] [Abstract][Full Text] [Related]
26. Identification of osteocalcin mRNA in nonosteoid tissue of rats and humans by reverse transcription-polymerase chain reaction.
Fleet JC; Hock JM
J Bone Miner Res; 1994 Oct; 9(10):1565-73. PubMed ID: 7817802
[TBL] [Abstract][Full Text] [Related]
27. Rapid control of transmembrane calcium influx by 1alpha,25-dihydroxyvitamin D3 and its analogues in rat osteoblast-like cells.
Nakagawa K; Tsugawa N; Okamoto T; Kishi T; Ono T; Kubodera N; Okano T
Biol Pharm Bull; 1999 Oct; 22(10):1058-63. PubMed ID: 10549855
[TBL] [Abstract][Full Text] [Related]
28. Nonhypercalcemic 1,25-(OH)2D3 analogs potently induce the human osteocalcin gene promoter stably transfected into rat osteosarcoma cells (ROSCO-2).
Morrison NA; Eisman JA
J Bone Miner Res; 1991 Aug; 6(8):893-9. PubMed ID: 1785378
[TBL] [Abstract][Full Text] [Related]
29. Nongenomic activation of the calcium message system by vitamin D metabolites in osteoblast-like cells.
Civitelli R; Kim YS; Gunsten SL; Fujimori A; Huskey M; Avioli LV; Hruska KA
Endocrinology; 1990 Nov; 127(5):2253-62. PubMed ID: 2226314
[TBL] [Abstract][Full Text] [Related]
30. 22-Oxacalcitriol: dissection of 1,25(OH)2D3 receptor-mediated and Ca2+ entry-stimulating pathways.
Farach-Carson MC; Abe J; Nishii Y; Khoury R; Wright GC; Norman AW
Am J Physiol; 1993 Nov; 265(5 Pt 2):F705-11. PubMed ID: 8238551
[TBL] [Abstract][Full Text] [Related]
31. Osteoblast responsiveness to 1alpha,25-dihydroxyvitamin D3 during spaceflight.
Kumei Y; Morita S; Nakamura H; Katano H; Ohya K; Shimokawa H; Sams CF; Whitson PA
Ann N Y Acad Sci; 2004 Dec; 1030():121-4. PubMed ID: 15659788
[TBL] [Abstract][Full Text] [Related]
32. Acute effect of 1,25-dihydroxyvitamin D3, prednisone, and 1,25-dihydroxyvitamin D3 plus prednisone on serum osteocalcin in normal individuals.
Nielsen HK; Brixen K; Kassem M; Mosekilde L
J Bone Miner Res; 1991 May; 6(5):435-41. PubMed ID: 2068950
[TBL] [Abstract][Full Text] [Related]
33. 1,25-Dihydroxyvitamin D3 interaction with dexamethasone and retinoic acid: effects on procollagen messenger ribonucleic acid levels in rat osteoblast-like cells.
Kim HT; Chen TL
Mol Endocrinol; 1989 Jan; 3(1):97-104. PubMed ID: 2915650
[TBL] [Abstract][Full Text] [Related]
34. 1 alpha,25-dihydroxyvitamin D3-induced increments in hepatocyte cytosolic calcium and lysophosphatidylinositol: inhibition by pertussis toxin and 1 beta,25-dihydroxyvitamin D3.
Baran DT; Sorensen AM; Honeyman TW; Ray R; Holick MF
J Bone Miner Res; 1990 May; 5(5):517-24. PubMed ID: 2368631
[TBL] [Abstract][Full Text] [Related]
35. Cardiac L-type calcium channel alpha 1-subunit is increased by cyclic adenosine monophosphate: messenger RNA and protein expression in intact bone.
Wang XT; Nagaba S; Nagaba Y; Leung SW; Wang J; Qiu W; Zhao PL; Guggino SE
J Bone Miner Res; 2000 Jul; 15(7):1275-85. PubMed ID: 10893676
[TBL] [Abstract][Full Text] [Related]
36. Dual 1,25-dihydroxyvitamin D3 signal response pathways in osteoblasts: cross-talk between genomic and membrane-initiated pathways.
Farach-Carson MC; Ridall AL
Am J Kidney Dis; 1998 Apr; 31(4):729-42. PubMed ID: 9531195
[TBL] [Abstract][Full Text] [Related]
37. Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3.
Arbour NC; Prahl JM; DeLuca HF
Mol Endocrinol; 1993 Oct; 7(10):1307-12. PubMed ID: 8264662
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional regulation of osteocalcin production by transforming growth factor-beta in rat osteoblast-like cells.
Noda M
Endocrinology; 1989 Feb; 124(2):612-7. PubMed ID: 2783570
[TBL] [Abstract][Full Text] [Related]
39. 1,25-dihydroxyvitamin D3 inhibits Osteocalcin expression in mouse through an indirect mechanism.
Zhang R; Ducy P; Karsenty G
J Biol Chem; 1997 Jan; 272(1):110-6. PubMed ID: 8995235
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional control of the osteocalcin gene by 1,25-dihydroxyvitamin D-2 and its 24-epimer in rat osteosarcoma cells.
Arbour NC; Darwish HM; DeLuca HF
Biochim Biophys Acta; 1995 Aug; 1263(2):147-53. PubMed ID: 7640305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
